Search Results - "Ak, Guntulu"

The relationship between nutritional status and prognosis in patients with locally advanced and advanced stage lung cancer by Gul, Busra, Metintas, Selma, Ak, Guntulu, Yilmaz, Senay, Metintas, Muzaffer

“…Purpose The study aimed to determine the poor nutritional status, related factors, and its effect on the prognosis of patients with locally advanced and…”
Get full text

Adoption of pleurectomy and decortication for malignant mesothelioma leads to similar survival as extrapleural pneumonectomy by Batirel, Hasan Fevzi, MD, PhD, Metintas, Muzaffer, MD, Caglar, Hale Basak, MD, Ak, Guntulu, MD, Yumuk, Perran Fulden, MD, Yildizeli, Bedrettin, MD, Yuksel, Mustafa, MD

“…Abstract Objective We changed our surgical approach to malignant pleural mesothelioma (MPM) in August 2011 and adopted pleurectomy and decortication (PD)…”
Get full text

What has changed in malignant mesothelioma between 1990 and 2019? A time- series analyses in Turkey by Metintas, Selma, Ak, Guntulu, Dundar, Emine, Metintas, Muzaffer

“…Objectives To investigate the changes in epidemiological and survival characteristics of malignant mesothelioma (MM) cases diagnosed in a 30-year period…”
Get full text

Potential years of life and productivity loss due to malignant mesothelioma in Turkey by Metintas, Selma, Ak, Guntulu, Metintas, Muzaffer

“…The study aimed to calculate years of life lost (YLL) and years of potential life lost (YPLL) due to malignant mesothelioma (MM) in Turkey. YLL was computed by…”
Get full text

Prediction of Radiation Pneumonitis With Machine Learning in Stage III Lung Cancer: A Pilot Study by Yakar, Melek, Etiz, Durmus, Metintas, Muzaffer, Ak, Guntulu, Celik, Ozer

“…Background: Radiation pneumonitis (RP) is a dose-limiting toxicity in lung cancer radiotherapy (RT). As risk factors in the development of RP, patient and…”
Get full text

Clinical value of fluorodeoxyglucose-positron emission tomography/computed tomography in differentiation of malignant mesothelioma from asbestos-related benign pleural disease: an observational pilot study by Yildirim, Huseyin, Metintas, Muzaffer, Entok, Emre, Ak, Guntulu, Ak, Ilknur, Dundar, Emine, Erginel, Sinan

“…Several studies have already addressed the potential role of an increased fluorine 18 fluorodeoxyglucose (18F FDG) uptake in identification of pleural…”
Get more information

Prognostic value of midkine, syndecan-1, hyaluronan synthase-2, sestrin-1, laminin subunit alpha-4 and fibulin-3 for malignant pleural mesothelioma by Akgun, Hakan, Metintas, Selma, Ak, Guntulu, Demirkol Canlı, Secil, Isbilen, Murat, Gure, Ali O, Metintas, Muzaffer

“…The prognosis of malignant pleural mesothelioma (MPM) is poor, with a limited survival time. In this study, we aimed to examine expression levels of genes…”
Get full text

Imaging in pleural mesothelioma: A review of the 14th International Conference of the International Mesothelioma Interest Group by Armato, Samuel G., Francis, Roslyn J., Katz, Sharyn I., Ak, Guntulu, Opitz, Isabelle, Gudmundsson, Eyjolfur, Blyth, Kevin G., Gupta, Ashish

“…•Preclinical mesothelioma models are used to inform clinical therapeutic strategies.•Contrast administration time delay impacts enhancement of mesothelioma…”
Get full text

Evaluation of Exudative Pleural Effusions: A Multicenter, Prospective, Observational Study by Ak, Guntulu, Metintas, Selma, Taskın, Ayse Naz, Uzel Sener, Melahat, Soyler, Yasemin, Yilmaz, Meltem, Turna, Akif, Akin Kabalak, Pınar, Bilaceroglu, Semra, Koksal, Deniz, Yilmaz Demirci, Nilgun, Sogukpinar, Ozlem, Boga, Sibel, Ercelik, Merve, Karadeniz, Gulistan, Polat, Gulru, Guldaval, Filiz, Aka Akturk, Ulku, Yilmaz, Senay, Ogan, Nalan, Yilmaz, Saliha, Esendagli, Dorina, Caglayan, Benan, Zeybek, Arife, Durmus Kocak, Nagihan, Mutlu, Pinar, Atinkaya Baytemir, Cansel, Sarbay, Ismail, Yilmaz, Ulku, Metintas, Muzaffer

“…Purpose The aim of this study is to determine the diagnostic performances of pleural procedures in undiagnosed exudative pleural effusions and to evaluate…”
Get full text

Prognostic factors according to the treatment schedule in malignant pleural mesothelioma by Ak, Guntulu, Metintas, Selma, Metintas, Muzaffer, Yildirim, Huseyin, Erginel, Sinan, Kurt, Emel, Alatas, Fusun, Cadirci, Omer

“…In this study, we aimed to investigate the factors affecting the survival of patients with malignant pleural mesothelioma (MPM) according to their treatment…”
Get more information

Three-dimensional evaluation of chemotherapy response in malignant pleural mesothelioma by Ak, Guntulu, Metintas, Muzaffer, Metintas, Selma, Yildirim, Huseyin, Ozkan, Ragip, Ozden, Hilmi

“…Abstract Objectives Measurement of tumor response to chemotherapy in malignant pleural mesothelioma (MPM) is problematic because of non-spherical tumor growth…”
Get full text

The safety of medical thoracoscopy in a group at high risk for complications by Metintas, Muzaffer, Ak, Guntulu, Yildirim, Huseyin, Danacioglu, Serpil, Dundar, Emine, Metintas, Selma

“…The use of medical thoracoscopy (MT) for the diagnosis and/or palliative treatment of pleural effusions is expected to become more widespread in the coming…”
Get full text

Local recurrence of tumor at sites of intervention in malignant pleural mesothelioma by Metintas, Muzaffer, Ak, Guntulu, Parspour, Sebnem, Yildirim, Huseyin, Erginel, Sinan, Alatas, Fusun, Batırel, Hasan F, Sivrikoz, Cumhur, Metintas, Selma, Dundar, Emine

“…Summary In malignant pleural mesothelioma (MPM) patients, local dissemination (LD) of the tumor is frequently observed at the sites of intervention where…”
Get full text

Timing of Thoracic Radiotherapy in Limited Stage Small Cell Lung Cancer: Results of Early Versus Late Irradiation from a Single Institution in Turkey by Bayman, Evrim, Etiz, Durmus, Akcay, Melek, Ak, Guntulu

“…Background: It is standard treatment to combine chemotherapy (CT) and thoracic radiotherapy (TRT) in treating patients with limited stage small cell lung…”
Get full text

Response by Metintas, Muzaffer, Ak, Guntulu, Metintas, Selma

Get full text

Lung cancer in individuals less than 50 years of age by Ak, Guntulu, Metintas, Muzaffer, Metintas, Selma, Yildirim, Huseyin, Erginel, Sinan, Alatas, Fusun

“…The aim of this study was to compare the epidemiologic, clinical, and laboratory characteristics and survival rates of younger and older patients with lung…”
Get full text

Environmental asbestos exposure and lung cancer by Metintas, Muzaffer, Ak, Guntulu, Metintas, Selma

“…Apart from living near an asbestos industry site, mine, or in an asbestos-contaminated house, environmental asbestos exposure is observed in certain regions…”
Get full text

Complex Genomic Rearrangement Patterns in Malignant Pleural Mesothelioma due to Environmental Asbestos Exposure by Tuncel, Tunç, Ak, Güntülü, Güneş, Hasan Veysi, Metintaş, Muzaffer

“…Malignant pleural mesothelioma (MPM) is a rare type of cancer, and its main risk factor is exposure to asbestos. Accordingly, our knowledge of the genomic…”
Get more information

Investigation of MTAP and BAP1 staining loss and P16/CDKN2A deletion in pleural cytology specimens and its role in the diagnosis of mesothelioma by Şeker, Nazli Sena, Tekin, Emel, Ak, Güntülü, Metintaş, Muzaffer, Metintaş, Selma, Dündar, Emine

“…Background Mesothelioma is a malignant neoplasm with a poor survival rate. We aimed to investigate the importance of BAP1, MTAP (IHC), and p16/CDKN2A…”
Get full text

Clinical Perspectives and Novel Preclinical Models of Malignant Pleural Mesothelioma: A Critical Review by Ebrahimi, Aliakbar, Ak, Güntülü, Özel, Ceren, İzgördü, Hüseyin, Ghorbanpoor, Hamed, Hassan, Shabir, Avci, Huseyin, Metintaş, Muzaffer

“…Pleural mesothelioma (PM), a rare malignant tumor explicitly associated with asbestos and erionite exposures, has become a global health problem due to limited…”
Get full text